Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
The 2019 emergence of, SARS-CoV-2 has tragically taken an immense toll on human life and far reaching impacts on society. There is a need to identify effective antivirals with diverse mechanisms of action in order to accelerate preclinical development. This study focused on five of the most establis...
Main Authors: | Matthew R Freidel, Roger S Armen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0246181 |
Similar Items
-
Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase
by: Joseph A. Newman, et al.
Published: (2021-08-01) -
Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
by: Muhammad Usman Mirza, et al.
Published: (2020-08-01) -
SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.
by: Christine Vazquez, et al.
Published: (2021-01-01) -
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
by: Robert N. Kirchdoerfer, et al.
Published: (2019-05-01) -
Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase
by: Roberto Benoni, et al.
Published: (2021-08-01)